Investigational Drug Information for Talsaclidine
✉ Email this page to a colleague
What is the drug development status for Talsaclidine?
Talsaclidine is an investigational drug.
There have been 7 clinical trials for Talsaclidine.
The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 1999.
The most common disease conditions in clinical trials are Dementia, Alzheimer Disease, and [disabled in preview]. The leading clinical trial sponsors are Boehringer Ingelheim and [disabled in preview].
Summary for Talsaclidine
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 459 |
| WIPO Patent Applications | 167 |
| Japanese Patent Applications | 32 |
| Clinical Trial Progress | Phase 2 (1999-05-01) |
| Vendors | 34 |
Recent Clinical Trials for Talsaclidine
| Title | Sponsor | Phase |
|---|---|---|
| Efficacy and Safety of Talsaclidine (Free Base) in Patients With Mild to Moderate Dementia of Alzheimer Type | Boehringer Ingelheim | Phase 2 |
| Effects on the Airway Lumen of Talsaclidine in Combination With Propranolol in Comparison to the Effects of the Monosubstances in Healthy Elderly Male Volunteers | Boehringer Ingelheim | Phase 1 |
| Follow-up Trial to Assess the Long-term Safety and Tolerability of Talsaclidine in Patients With Mild to Moderate Dementia of the Alzheimer Type | Boehringer Ingelheim | Phase 2/Phase 3 |
Clinical Trial Summary for Talsaclidine
Top disease conditions for Talsaclidine
Top clinical trial sponsors for Talsaclidine
US Patents for Talsaclidine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
